Urachal cancer

Active Research Protocols

  1. 12-C-0205 – A Phase II Study of Cabozantinib (XL184) in Patients With Advanced/Metastatic Urothelial Carcinoma
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014